References
- AchkarJMCasadevallAGlatman-FreedmanA2007Immunological options for the treatment of tuberculosis: evaluation of novel therapeutic approachesExpert Rev Anti Infect Ther54617417547510
- BekkerLGHaslettPMaartensG2000Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosisJ Infect Dis1819546510720518
- ChkhetianyRPylypchukVArjanovaO2007Comparative effect of an immunomodulator Immunoxel (Dzherelo) when used alone or in combination with antiretroviral therapy in drug-naïve HIV infected individualsInt J Biotechnol926776
- ErshovFI2003Use of immunomodulators in viral infectionsAntibiot Khimioter48273214558416
- GuptaANayakURamMByramjee Jeejeebhoy Medical College-Johns Hopkins University Study Group2007Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002–2005Clin Infect Dis45241917578786
- KalouMSassan-MorokroMAbouyaL2005Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d'IvoireJ Med Virol75202815602734
- KaufmannSH2006Tuberculosis: back on the immunologists’ agendaImmunity24351716618591
- KhauadamovaGTAruinovaBKBidaibaevNS2001Special features of the course of tuberculosis in HIV-infected patientsProbl Tuberk534611588958
- KhudzikLBSalinaTLParolinaLE1998Immunotherapy of pulmonary tuberculosisProbl Tuberk623610067345
- KizzaHMRodriguezBQuinones-MateuM2005Persistent replication of human immunodeficiency virus type 1 despite treatment of pulmonary tuberculosis in dually infected subjectsClin Diagn Lab Immunol12129830416275944
- ManasEPulidoFPenaJM2004Impact of tuberculosis on the course of HIV-infected patients with a high initial CD4 lymphocyte countInt J Tuberc Lung Dis8451715141738
- Mayanja-KizzaHJones-LopezEOkweraAUganda-Case Western Research Collaboration2005Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in UgandaJ Infect Dis1918566515717259
- Melnik VP, Panasyuk OV, Pylypchuk VS, et al. 1999. Deployment of herbal preparations Dzherelo and Svitanok for combination therapy of pulmonary tuberculosis. Medical Institute of Ukrainian Association of People’s Medicine. Information Bulletin of the Ministry of Health. UDK:616.24-002.5-085-038:615.017. Kiev, Ukraine.
- MorrisLMartinDJBredellH2003Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patientsJ Infect Dis18719677112792875
- NewtonSMLauCWrightCW2000A review of antimycobacterial natural productsPhytother Res143032210925394
- NikolaevaLGPylypchukVSVolyanskiiYL2008Effect of immunomodulator Dzherelo on CD4+ T-lymphocyte counts and viral load in HIV infected patients receiving anti-retroviral therapyRes J Pharmacol2812
- NikolayevskyyVVBrownTJBazhoraYI2007Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern UkraineClin Microbiol Infect131293817328724
- PrihodaNDArjanovaOVYurchenkoLV2007Open label trial of adjuvant immunotherapy with Dzherelo, Svitanok and Lizorm, in MDR-TB, XDR-TB and TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOTJ Med Plant Res111722
- PylypchukVS2003Clinical and experimental aspects rationalizing the need for immunotherapy in the treatment of patients with tuberculosisProbl Ecol Med Gen Clin Immunol707584
- ReidAScanoFGetahunH2006Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaborationLancet Infect Dis64839516870527
- SerbinaNVLazarevicVFlynnJL2001CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infectionJ Immunol1676991700011739519
- SvistunovaASPineginBVSelitskaiaRP2002The use of immunomodulator likopid in the combined treatment pulmonary tuberculosisProbl Tuberk321512066527
- TomiokaH2004Adjunctive immunotherapy of mycobacterial infectionsCurr Pharm Des10329731215544517
- van der WerfMJYegorovaOBChentsovaN2006Tuberculosis-HIV co-infection in Kiev City, UkraineEmerg Infect Dis12766816704834
- WallisRS2005Reconsidering adjuvant immunotherapy for tuberculosisClin Infect Dis41201815983916
- ZaitzevaSI2006Clinical efficacy of phytopreparation Dzherelo and its influence on the functional status of liver in patients with destructive forms of tuberculosisProbl Ecol Med Gen Clin Immunol71–7213240